Trials / Recruiting
RecruitingNCT04330963
International Swiss Primary Hypersomnolence and Narcolepsy Cohort Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- Insel Gruppe AG, University Hospital Bern · Academic / Other
- Sex
- All
- Age
- 10 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Swiss Primary Hypersomnolence and Narcolepsy Cohort Study (SPHYNCS) is a cohort study on disease presentation and long-term course with an exploratory approach to detect biomarkers.
Detailed description
An exploratory prospective, national, multi-center cohort study on clinical, electrophysiological and biological biomarkers of disease presentation and course.
Conditions
Timeline
- Start date
- 2020-01-06
- Primary completion
- 2024-12-30
- Completion
- 2026-06-30
- First posted
- 2020-04-02
- Last updated
- 2023-04-20
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04330963. Inclusion in this directory is not an endorsement.